Quantum dots and its advancement in the treatment of Parkinson’s disease: a review

  • Rupesh Kumar mani Department of Pharmacology, Sri Adichunchanagiri college of Pharmacy, Adichunchanagiri university, B G nagara, Mandya, Karnataka
  • Chandan K Department of Pharmacology, Sri Adichunchanagiri college of Pharmacy, Adichunchanagiri university, B G nagara, Mandya, Karnataka.
  • Bharathi D R Department of Pharmacology, Sri Adichunchanagiri college of Pharmacy, Adichunchanagiri university, B G nagara, Mandya, Karnataka.
  • Syed Sagheer Ahmed Department of Pharmacology, Sri Adichunchanagiri college of Pharmacy, Adichunchanagiri university, B G nagara, Mandya, Karnataka.
  • Gurusidda Department of Pharmacology, Sri Adichunchanagiri college of Pharmacy, Adichunchanagiri university, B G nagara, Mandya, Karnataka.

Abstract

Quantum dots also known as zero-dimensional Nano materials, which have very distinctive Properties Such as Electro chemiluminescent, Fluorescent, Photoluminescent. because of their unique properties quantum dots have a revolutionary role in Biomedical research. Quantum dots Like Zinc oxide quantum dots, Graphene Quantum dots, Glutathione conjugated carbon quantum dots (GSH-CQDs) and L-cysteine capped ZnS:Mn quantum dots have many applications in diagnosis and treatment. They can easily cross blood brain barrier hence they be used as drug carriers further more because of their capabilities they gather widespread attention in the biomedical research.

Keywords: Quantum dots, Nano materials, GSH-CQDs, Parkinson’s disease

Downloads

Download data is not yet available.

References

1. Saini R, Saini S, Sharma S. Nanotechnology: the future medicine. Journal of cutaneous and aesthetic surgery. 2010 Jan;3(1):32.
2. Singh A, Dubey S, Dubey HK. Nanotechnology: the future engineering. Nanotechnology. 2019 Apr;6(2):230-3.
3. Azzawi M, Seifalian A, Ahmed W. Nanotechnology for the diagnosis and treatment of diseases. Nanomedicine. 2016 Aug;11(16):2025-7. Azzawi M, Seifalian A, Ahmed W. Nanotechnology for the diagnosis and treatment of diseases. Nanomedicine. 2016 Aug;11(16):2025-7
4. Patil M, Mehta DS, Guvva S. Future impact of nanotechnology on medicine and dentistry. Journal of Indian society of periodontology. 2008 May;12(2):34
5. Beitz, J.M., 2014. Parkinson’s disease: a review. Front Biosci (Schol Ed), 6(6), pp.65-74.
6. Mendes Filho, D., dC Ribeiro, P., Oliveira, L.F., de Paula, D.R., Capuano, V., de Assunção, T.S. and da Silva, V.J., 2018. Therapy with mesenchymal stem cells in Parkinson disease: history and perspectives. The Neurologist, 23(4), pp.141-147.
7. Wagner AM, Knipe JM, Orive G, Peppas NA. Quantum dots in biomedical applications. Acta biomaterialia. 2019 Aug 1;94:44-63
8. Lin D, Li M, Gao Y, Yin L, Guan Y. Brain-targeted gene delivery of ZnO quantum dots nanoplatform for the treatment of Parkinson disease. Chemical Engineering Journal. 2022 Feb 1;429:132210.
9. Kim D, Yoo JM, Hwang H, Lee J, Lee SH, Yun SP, Park MJ, Lee M, Choi S, Kwon SH, Lee S. Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease. Nature nanotechnology. 2018 Sep;13(9):812-8.
10. Ghaeidamini M, Bernson D, Sasanian N, Kumar R, Esbjörner EK. Graphene oxide sheets and quantum dots inhibit α-synuclein amyloid formation by different mechanisms. Nanoscale. 2020;12(37):19450-60.
11. Diaz-Diestra D, Thapa B, Beltran-Huarac J, Weiner BR, Morell G. L-cysteine capped ZnS: Mn quantum dots for room-temperature detection of dopamine with high sensitivity and selectivity. Biosensors and Bioelectronics. 2017 Jan 15; 87:693-700
12. Park SW, Kim TE, Jung YK. Glutathione-decorated fluorescent carbon quantum dots for sensitive and selective detection of levodopa. Analytica Chimica Acta. 2021 Jun 22;1165:338513.
Published
28/04/2022
Statistics
376 Views | 236 Downloads
Citatons
How to Cite
Mani, R. K., K, C., R, B. D., Ahmed, S. S., & Gurusidda. (2022). Quantum dots and its advancement in the treatment of Parkinson’s disease: a review. Journal of Innovations in Applied Pharmaceutical Science (JIAPS), 7(1), 61-63. https://doi.org/10.37022/jiaps.v7i1.316
Section
Review Article(S)